Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PFE | NYSE | USD | Real-time | |
PFE | Mexico | MXN | Delayed | |
1PFE | Milan | EUR | Real-time | |
PFE | TradeGate | EUR | Delayed | |
PFE | Frankfurt | EUR | Delayed | |
PFE | Hamburg | EUR | Delayed | |
PFE | Xetra | EUR | Delayed | |
PFE | Santiago | USD | Delayed | |
PFE | Buenos Aires | ARS | Delayed | |
PFIZ34 | B3 | BRL | Delayed | |
PFE | Vienna | EUR | Real-time | |
PFE | Ukraine | UAH | Delayed | |
PFE_KZ | KASE | USD | Delayed | |
PFE_KZTQBD | KASE | USD | Delayed | |
PFE_KZTQKD | KASE | USD | Delayed | |
PFE | Colombia | COP | Delayed | |
PFE | Lima | USD | Delayed |
By Oliver Gray Investing.com - U.S. stock futures were trading slightly higher during Monday’s evening deals, after major benchmark indices finished the regular session lower as...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Strong Buy | Buy | Buy | Sell | Strong Sell |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Strong Sell |
Summary | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Bullish Engulfing | 1D | Current | |||
Completed Patterns | |||||
Bullish Engulfing | 1M | 1 | Mar 24 | ||
Three Outside Up | 30 | 3 | Apr 19, 2024 22:00 | ||
Bullish Engulfing | 30 | 4 | Apr 19, 2024 21:30 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
NYSE | 25.96 | 0.00 | 0.00 | 27,850,557 | +2.26% | USD | |||
Mexico | 445.05 | 443.31 | 446.77 | 3,855 | +2.65% | MXN | |||
Milan | 24.18 | 0.00 | 0.00 | 1,249 | +1.72% | EUR | |||
TradeGate | 24.35 | 24.36 | 24.39 | 77,816 | +2.29% | EUR | |||
Frankfurt | 24.22 | 24.38 | 24.40 | 6,728 | +2.00% | EUR | |||
Hamburg | 24.21 | 24.37 | 24.40 | 700 | +1.49% | EUR | |||
Xetra | 24.135 | 24.135 | 24.145 | 39,809 | +1.62% | EUR | |||
Santiago | 26.92 | 0.00 | 0.00 | 50 | 0.00% | USD | |||
Buenos Aires | 6,930.00 | 6,915.00 | 6,930.00 | 14,664 | +2.90% | ARS | |||
B3 | 33.66 | 33.66 | 33.72 | 6,114 | +1.17% | BRL | |||
Vienna | 23.890 | 23.820 | 23.890 | 0 | +0.00% | EUR | |||
Ukraine | 1,014.00 | 0.00 | 0.00 | 2 | -7.23% | UAH | |||
KASE | 25.46 | 25.35 | 25.46 | 73 | +0.04% | USD | |||
KASE | 0.00% | USD | |||||||
KASE | 27.67 | 27.62 | 28.19 | 0 | 0.00% | USD | |||
Colombia | 98,660.00 | 0.00 | 0.00 | 392 | -1.14% | COP | |||
Lima | 25.58 | 0.00 | 0.00 | 1,009 | -1.12% | USD |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
DMCI | 10.080 | 10.360 | 10.040 | -0.640 | -5.97% | 7.20M | 19/04 | ||
LT Group | 9.570 | 9.650 | 9.430 | -0.030 | -0.31% | 2.43M | 19/04 | ||
AREIT, | 33.45 | 34.35 | 33.00 | -0.75 | -2.19% | 634.00K | 19/04 | ||
Bank of the Philippine Islands | 124.00 | 124.00 | 119.10 | 0.00 | 0.00% | 1.94M | 19/04 | ||
Semirara Mining | 30.00 | 31.00 | 29.85 | -1.00 | -3.23% | 1.55M | 19/04 | ||
Ayala Land | 27.000 | 27.800 | 27.000 | -0.950 | -3.40% | 16.36M | 19/04 | ||
Bright Kindle | 1.360 | 1.540 | 1.250 | -0.140 | -9.33% | 4.43M | 19/04 | ||
Converge Information Communications Technology Sol | 8.56 | 9.15 | 8.50 | -0.53 | -5.83% | 3.48M | 19/04 | ||
Universal Robina | 90.00 | 95.50 | 90.00 | -3.00 | -3.23% | 1.96M | 19/04 | ||
PLDT | 1,300.00 | 1,314.00 | 1,290.00 | 0.00 | 0.00% | 43.87K | 19/04 |
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review